Literature DB >> 17195468

Integration of technologies for hepatic tissue engineering.

Yaakov Nahmias1, Francois Berthiaume, Martin L Yarmush.   

Abstract

The liver is the largest internal organ in the body, responsible for over 500 metabolic, regulatory, and immune functions. Loss of liver function leads to liver failure which causes over 25,000 deaths/year in the United States. Efforts in the field of hepatic tissue engineering include the design of bioartificial liver systems to prolong patient's lives during liver failure, for drug toxicity screening and for the study of liver regeneration, ischemia/reperfusion injury, fibrosis, viral infection, and inflammation. This chapter will overview the current state-of-the-art in hepatology including isolated perfused liver, culture of liver slices and tissue explants, hepatocyte culture on collagen "sandwich" and spheroids, coculture of hepatocytes with non-parenchymal cells, and the integration of these culture techniques with microfluidics and reactor design. This work will discuss the role of oxygen and medium composition in hepatocyte culture and present promising new technologies for hepatocyte proliferation and function. We will also discuss liver development, architecture, and function as they relate to these culture techniques. Finally, we will review current opportunities and major challenges in integrating cell culture, bioreactor design, and microtechnology to develop new systems for novel applications.

Entities:  

Mesh:

Year:  2007        PMID: 17195468     DOI: 10.1007/10_029

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  44 in total

Review 1.  Cell therapies for liver diseases.

Authors:  Yue Yu; James E Fisher; Joseph B Lillegard; Brian Rodysill; Bruce Amiot; Scott L Nyberg
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

Review 2.  Embryonic and induced pluripotent stem cells as a model for liver disease.

Authors:  Hiroshi Yagi; Edgar Tafaleng; Masaki Nagaya; Marc C Hansel; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Crit Rev Biomed Eng       Date:  2009

3.  A novel 3D liver organoid system for elucidation of hepatic glucose metabolism.

Authors:  Yanhua Lu; Guoliang Zhang; Chong Shen; Korkut Uygun; Martin L Yarmush; Qin Meng
Journal:  Biotechnol Bioeng       Date:  2011-10-19       Impact factor: 4.530

4.  Transport-mediated angiogenesis in 3D epithelial coculture.

Authors:  Ryo Sudo; Seok Chung; Ioannis K Zervantonakis; Vernella Vickerman; Yasuko Toshimitsu; Linda G Griffith; Roger D Kamm
Journal:  FASEB J       Date:  2009-02-26       Impact factor: 5.191

5.  Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model.

Authors:  Rohit Jindal; Yaakov Nahmias; Arno W Tilles; Francois Berthiaume; Martin L Yarmush
Journal:  FASEB J       Date:  2009-02-26       Impact factor: 5.191

Review 6.  Hepatocyte polarity.

Authors:  Aleksandr Treyer; Anne Müsch
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

7.  Preparation and characterization of chitosan/galactosylated hyaluronic acid scaffolds for primary hepatocytes culture.

Authors:  Jinyong Fan; Yi Shang; Yingjin Yuan; Jun Yang
Journal:  J Mater Sci Mater Med       Date:  2009-07-30       Impact factor: 3.896

8.  Bile canaliculi formation by aligning rat primary hepatocytes in a microfluidic device.

Authors:  Yosuke Nakao; Hiroshi Kimura; Yasuyuki Sakai; Teruo Fujii
Journal:  Biomicrofluidics       Date:  2011-06-29       Impact factor: 2.800

9.  Layered long-term co-culture of hepatocytes and endothelial cells on a transwell membrane: toward engineering the liver sinusoid.

Authors:  Young Bok Abraham Kang; Siddhartha Rawat; Joseph Cirillo; Michael Bouchard; Hongseok Moses Noh
Journal:  Biofabrication       Date:  2013-11-26       Impact factor: 9.954

10.  Long-term culture and coculture of primary rat and human hepatocytes.

Authors:  Maria Shulman; Yaakov Nahmias
Journal:  Methods Mol Biol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.